Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...

At ELRIG’s 2025 meeting in GSK’s Stevenage campus, Recursion’s Executive Director of Computational Biology, Dr. Kelly ...

Users reporting shared symbols and patterns in chatbot conversations have formed an online community called Spiralism, ...

A roundup of the bold, divisive, and conversation-starting books from 2025 that challenged beliefs and refused to blend into ...

It’s wild to think that a math puzzle from the 1200s is now helping power AI, encryption, and the digital world we live in. ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.

Is that the case? Let's look into it and decide whether the company is worth investing in.

Structured data turns the dark funnel of AI search into actionable visibility, bridging what marketers can’t yet measure.

The authors have performed a potentially valuable new kind of analysis in connectomics, mapping to an interesting developmental problem of synaptic input to sensory neurons. While the analysis itself ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

HackerRank offers a good amount of free coding challenges and practice problems for individuals looking to hone their skills. While basic access is free, HackerRank has premium features and ...